Two Sepracor drugs suffer setback, shares tumble | Reuters
Links shared publicly online about this topic.
- 1,927total visits
Two Sepracor drugs suffer setback, shares tumble | Reuters
New york (reuters) - u.s. biotechnology company sepracor inc on wednesday suffered a double setback as its experimental depression drug failed a mid-stage study and u.s. regulators halted
View full resource at reuters.com
Tags: Sleep, Insomnia Medication, Depression, Antidepressant, Drug, Children's Health, Lunesta
Most Recently Shared on July 2, 2009 at 5:25 pm By:
Use of Lunesta (sleep aid) in children? This is just another way 4 Sepracor to extend drug's patent: http://bit.ly/ZSNGe
Advertisement
